Lineage ambiguity, infidelity, and promiscuity in immunophenotypically complex acute leukemias: Genetic and morphologic correlates

American Journal of Clinical Pathology

Volumn 128, Issue 4, 2007, Pages 545-548

  Bagg, Adam ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Acute leukemia; Acute lymphoblastic leukemia; Acute myeloid leukemia; Biphenotypic acute leukemia; Flow cytometry; Molecular diagnosis; Morphology

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; CELL LINEAGE; CHROMOSOME ABERRATION; CYTOCHEMISTRY; CYTOGENETICS; DIAGNOSTIC ACCURACY; DISEASE COURSE; EDITORIAL; FLOW CYTOMETRY; GENETIC HETEROGENEITY; HUMAN; IMMUNOPHENOTYPING; MOLECULAR GENETICS; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WORLD HEALTH ORGANIZATION;

ACUTE DISEASE; CELL LINEAGE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOID; MOLECULAR DIAGNOSTIC TECHNIQUES;

EID: 35348846512     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/NQQQY37HPDNAMC1Y     Document Type: Editorial

References (20)

1. Mrozek K, Heinonen K, Bloomfield CD. Clinical importance of cytogenetics in acute myeloid leukaemia. Best Pract Res Clin Haematol. 2001;14:19-47.
2. Baldus CD, Mrozek K, Marcucci G, et al. Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review. Br J Haematol. 2007;137:387-400.
3. Thalhammer-Scherrer R, Mitterbauer G, Simonitsch I, et al. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination. Am J Clin Pathol. 2002;117:380-389.
4. Weir EG, Borowitz MJ. Flow cytometry in the diagnosis of acute leukemia. Semin Hematol. 2001;38:124-138.
5. Sainty D, Liso V, Cantu-Rajnoldi A, et al, for the Groupe Français d'Hématologie Cellulaire, Groupe Français de Cytogé nétique Hématologique, UK Cancer Cytogenetics Group, and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies." A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements. Blood. 2000;96:1287-1296.
6. Kussick SJ, Stirewalt DL, Yi HS, et al. A distinctive nuclear morphology in acute myeloid leukemia is strongly associated with loss of HLA-DR expression and FLT3 internal tandem duplication. Leukemia. 2004;18:1591-1598.
7. Chen W, Rassidakis GZ, Li J, et al. High frequency of NPM1 gene mutations in acute myeloid leukemia with prominent nuclear invaginations ("cuplike" nuclei) [letter]. Blood. 2006;108:1783-1784.
8. Wouters BJ, Alberich Jorda M, Keeshan K, et al. Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1. Blood. 2007. [Epub ahead of print].
9. De J, Zanjani R, Hibbard M, et al. Immunophenotypic profile predictive of KIT activating mutations in AML1-ETO leukemia. Am J Clin Pathol. 2007;128:550-557.
10. Herling M, Jones D. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells. Am J Clin Pathol. 2007;127:687-700.
11. Bataille R, Jego G, Robillard N, et al. The phenotype of normal, reactive and malignant plasma cells: identification of "many and multiple myelomas" and of new targets for myeloma therapy. Haematologica. 2006;91:1234-1240.
12. Xu Y, McKenna RW, Karandikar NJ, et al. Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis. Am J Clin Pathol. 2005;124:799-806.
13. Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995;9:1783-1786.
14. Jaffe E, Harris N, Stein HVJ, et al, ed. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues [2nd printing]. Lyon, France: IARC Press; 2001. World Health Organization Classification of Tumours.
15. Aribi A, Bueso-Ramos C, Estey E, et al. Biphenotypic acute leukaemia: a case series. Br J Haematol. 2007;138:213-216.
16. Ratei R, Karawajew L, Lacombe F, et al. Discriminant function analysis as decision support system for the diagnosis of acute leukemia with a minimal four color screening panel and multiparameter flow cytometry immunophenotyping. Leukemia. 2007;21:1204-1211.
17. Chapiro E, Delabesse E, Asnafi V, et al. Expression of T-lineage-affiliated transcripts and TCR rearrangements in acute promyelocytic leukemia: implications for the cellular target of t(15;17). Blood. 2006;108:3484-3493.
18. Tiacci E, Pileri S, Orleth A, et al. PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia. Cancer Res. 2004;64:7399-7404.
19. Bhargava P, Kallakury BV, Ross JS, et al. CD79a is heterogeneously expressed in neoplastic and normal myeloid precursors and megakaryocytes in an antibody clone-dependent manner. Am J Clin Pathol. 2007;128:306-313.
20. Rosai J. Why microscopy will remain a cornerstone of surgical pathology. Lab Invest. 2007;87:403-408.